You are here: Industry Insights > Renal Disease

News List

Novartis’ rare renal disease candidate shows promise in phase II pharmatimes
October 29, 2020
Interim analysis results for Novartis’ rare renal disease candidate iptacopan proved promising in a phase II study of the investigational drug.
Bird Rock Bio Files IND for Study of Nimacimab for Renal Diseases americanpharmaceuticalreview
June 05, 2020
Bird Rock Bio announced the Company has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a phase 2 clinical study of nimacimab, also known as RYI-018 ...
Fresenius Medical Care unveils Malaysia’s first peritoneal dialysis products manufacturing plant pharmaasia
September 18, 2017
The state-of-the-art facility will be Fresenius Medical Care's regional manufacturing hub for Southeast Asia.
FDA OKs Bard’s Lutonix drug-coated balloon for renal disease complication fiercebiotech
August 29, 2017
The Lutonix drug-coated balloon is now FDA-approved to treat stenosis in the AV fistulae of renal disease patients, which can reduce the number of reinterventions they need to keep up their dialysis treatments.
Natco gets US FDA nod to market renal disease drug expressbpd
August 15, 2017
The product, as the first generic, will be launched shortly in the US market